73 results
DEFC14A
FBRX
Forte Biosciences Inc
24 Aug 23
Proxy in contested solicitation
6:15am
platform for managing chronic diseases. Mr. Kornfeld was previously Portfolio Manager, Research Analyst and Health Care Sector Team Leader
D
blj556hmy2 g5
9 Aug 23
$25.01 mm in equity / options, sold $25.01 mm, 27 investors
12:23pm
PREC14A
ij03o e4hfd
2 Aug 23
Preliminary proxy with contested solicitation
5:28pm
8-K
EX-10.1
uk89l82ajwkmc
1 Aug 23
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
4:06pm